passlisted in Coinbase#1 by calls of 844 on this host
0.005 USDC
per call, as the listing declares it on eip155:
- Validation state
- pass
- Uptime, 7 / 30 / 90 days
- 100% / 100% / 100%
- Calls, trailing 30 days
- 3
- Unique payers, trailing 30 days
- 1
- Last called
- 2026-09-28 13:45 UTC
- First observed by TOLLderived
- 2026-09-28
- Pricederived
- 0.005 USDC
- Networks
- 1
How big is this endpoint among the ones like it?
No trace is drawn of this endpoint’s own volume. Its counters have changed 1 time across 11 observations, and 3 changes are the fewest this site will draw a trace through, because two points and a guess are not a series. Every observation is in the JSON.
Of api.magentlab.com's 844 listings, calc hfa icos anthracycline ranks tied 1st by calls with 5 others.
Requests carry a JSON body with the field items.
A response from calc hfa icos anthracycline, as declared, includes path, count and items.
Over 30 days: 3 calls, one payer.
The last call to calc hfa icos anthracycline came 4 days before the snapshot, 2026-09-28.
calc hfa icos anthracycline is priced at 0.005 USDC on Base.
api.magentlab.com serves calc hfa icos anthracycline, a POST endpoint that TOLL places in search, listed in the Coinbase registry.
calc hfa icos anthracycline answered the sweep of 2026-10-01 with a valid 402, as at every sweep since 2026-09-28.
Closest in price to calc hfa icos anthracycline within search: tweets search at x402.twit.sh and search site at x402.agentutility.ai.
calc hfa icos anthracycline is priced above 22% of comparable listings in search.
Within search, 67% of endpoints with counters have fewer calls.
The wallet paid by calc hfa icos anthracycline is the payee of 844 endpoints on one host.
The seller's tags on calc hfa icos anthracycline are hfa-icos, anthracycline, cardio-oncology and hemodynamics.
316 other listings in search declare exactly the same price.
the payment options, as of 2026-10-02 05:34 UTC · method · pinnable
| registry | network | asset | amount | scheme | pay to |
|---|---|---|---|---|---|
| Coinbase | eip155: | USDC | 0.005 USDC | exact | 0x836Be2…c19Ee2 |
the checks, as of 2026-10-01 06:15 UTC · method · pinnableendpoint answered HTTP 402
No named check failed.
Every sweep that observed this endpoint, newest first.
| observed, UTC | state | failed checks | sweep |
|---|---|---|---|
| 2026-10-01 06:15 UTC | pass | 0 | daily-2026-10-01 |
| 2026-09-30 04:20 UTC | pass | 0 | daily-2026-09-30 |
| 2026-09-29 17:54 UTC | pass | 0 | daily-2026-09-29 |
| 2026-09-28 16:51 UTC | pass | 0 | daily-2026-09-28 |
| 2026-09-28 14:09 UTC | pass | 0 | new-after-daily-2026-09-28 |
Presence in a registry, not liveness of the service (method). Newest first.
- listed in Coinbase
From the registry record, not validated by TOLL.the declared schema, as of 2026-09-28 13:45 UTC · method · live
The input and output block
{
"input": {
"body": {
"items": [
{
"ckd": false,
"obesity": false,
"diabetes": false,
"age_years": 50,
"elevated_bnp": false,
"hypertension": false,
"lvef_percent": 60,
"stable_angina": false,
"elevated_troponin": false,
"previous_anthracycline": false,
"current_or_significant_smoker": false,
"severe_valvular_heart_disease": false,
"heart_failure_or_cardiomyopathy": false,
"mi_or_coronary_revascularization": false,
"previous_non_anthracycline_chemo": false,
"prior_left_chest_or_mediastinal_rt": false
},
{
"ckd": false,
"obesity": false,
"diabetes": false,
"age_years": 50,
"elevated_bnp": false,
"hypertension": false,
"lvef_percent": 60,
"stable_angina": false,
"elevated_troponin": false,
"previous_anthracycline": false,
"current_or_significant_smoker": false,
"severe_valvular_heart_disease": false,
"heart_failure_or_cardiomyopathy": false,
"mi_or_coronary_revascularization": false,
"previous_non_anthracycline_chemo": false,
"prior_left_chest_or_mediastinal_rt": false
}
]
},
"type": "http",
"method": "POST"
},
"output": {
"type": "json",
"example": {
"path": "/api/calc/hfa_icos_anthracycline",
"count": 2,
"items": [
{
"formula": "hfa_icos_anthracycline",
"citation": {
"id": "lyon-2020",
"doi": "10.1002/ejhf.1920",
"pmid": "32458582",
"title": "Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society",
"source": "Eur J Heart Fail. 2020;22(11):1945-1960",
"authors": "Lyon AR, Dent S, Stanway S, et al."
},
"age_years": 50,
"components": [
{
"tier": "very_high",
"factor": "heart_failure_or_cardiomyopathy",
"points": 0,
"present": false
},
{
"tier": "high",
"factor": "severe_valvular_heart_disease",
"points": 0,
"present": false
},
{
"tier": "high",
"factor": "mi_or_coronary_revascularization",
"points": 0,
"present": false
},
{
"tier": "high",
"factor": "stable_angina",
"points": 0,
"present": false
},
{
"tier": "high",
"factor": "previous_anthracycline",
"points": 0,
"present": false
},
{
"tier": "high",
"factor": "prior_left_chest_or_mediastinal_rt",
"points": 0,
"present": false
},
{
"tier": "medium_1",
"factor": "elevated_troponin",
"points": 0,
"present": false
},
{
"tier": "medium_1",
"factor": "elevated_bnp",
"points": 0,
"present": false
},
{
"tier": "medium_1",
"factor": "hypertension",
"points": 0,
"present": false
},
{
"tier": "medium_1",
"factor": "diabetes",
"points": 0,
"present": false
},
{
"tier": "medium_1",
"factor": "ckd",
"points": 0,
"present": false
},
{
"tier": "medium_1",
"factor": "previous_non_anthracycline_chemo",
"points": 0,
"present": false
},
{
"tier": "medium_1",
"factor": "current_or_significant_smoker",
"points": 0,
"present": false
},
{
"tier": "medium_1",
"factor": "obesity",
"points": 0,
"present": false
},
{
"tier": "none",
"value": 50,
"factor": "age_years",
"points": 0,
"present": false
},
{
"tier": "none",
"value": 60,
"factor": "lvef_percent",
"points": 0,
"present": false
}
],
"disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
"risk_level": "low",
"lvef_percent": 60,
"medium_points": 0,
"formula_expression": "very_high if heart_failure_or_cardiomyopathy; else high if any High factor (severe_valvular_heart_disease, mi_or_coronary_revascularization, stable_angina, lvef_percent<50, age_years>=80, previous_anthracycline, prior_left_chest_or_mediastinal_rt) OR medium_points>=5; else medium if medium_points in 2..4; else low (no factors or one Medium 1). medium_points sums Medium 1 (=1: elevated_troponin, elevated_bnp, hypertension, diabetes, ckd, previous_non_anthracycline_chemo, current_or_significant_smoker, obesity) and Medium 2 (=2: lvef_percent 50-54, age_years 65-79) only. Age and LVEF use the highest matching printed band. Lyon 2020 HFA-ICOS anthracycline table. cardiotoxicity_guide is that paper's expert-opinion guide: low <2%, medium 2-9%, high 10-19%, very high >=20%",
"cardiotoxicity_guide": "<2%"
},
{
"formula": "hfa_icos_anthracycline",
"citation": {
"id": "lyon-2020",
"doi": "10.1002/ejhf.1920",
"pmid": "32458582",
"title": "Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society",
"source": "Eur J Heart Fail. 2020;22(11):1945-1960",
"authors": "Lyon AR, Dent S, Stanway S, et al."
},
"age_years": 50,
"components": [
{
"tier": "very_high",
"factor": "heart_failure_or_cardiomyopathy",
"points": 0,
"present": false
},
{
"tier": "high",
"factor": "severe_valvular_heart_disease",
"points": 0,
"present": false
},
{
"tier": "high",
"factor": "mi_or_coronary_revascularization",
"points": 0,
"present": false
},
{
"tier": "high",
"factor": "stable_angina",
"points": 0,
"present": false
},
{
"tier": "high",
"factor": "previous_anthracycline",
"points": 0,
"present": false
},
{
"tier": "high",
"factor": "prior_left_chest_or_mediastinal_rt",
"points": 0,
"present": false
},
{
"tier": "medium_1",
"factor": "elevated_troponin",
"points": 0,
"present": false
},
{
"tier": "medium_1",
"factor": "elevated_bnp",
"points": 0,
"present": false
},
{
"tier": "medium_1",
"factor": "hypertension",
"points": 0,
"present": false
},
{
"tier": "medium_1",
"factor": "diabetes",
"points": 0,
"present": false
},
{
"tier": "medium_1",
"factor": "ckd",
"points": 0,
"present": false
},
{
"tier": "medium_1",
"factor": "previous_non_anthracycline_chemo",
"points": 0,
"present": false
},
{
"tier": "medium_1",
"factor": "current_or_significant_smoker",
"points": 0,
"present": false
},
{
"tier": "medium_1",
"factor": "obesity",
"points": 0,
"present": false
},
{
"tier": "none",
"value": 50,
"factor": "age_years",
"points": 0,
"present": false
},
{
"tier": "none",
"value": 60,
"factor": "lvef_percent",
"points": 0,
"present": false
}
],
"disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
"risk_level": "low",
"lvef_percent": 60,
"medium_points": 0,
"formula_expression": "very_high if heart_failure_or_cardiomyopathy; else high if any High factor (severe_valvular_heart_disease, mi_or_coronary_revascularization, stable_angina, lvef_percent<50, age_years>=80, previous_anthracycline, prior_left_chest_or_mediastinal_rt) OR medium_points>=5; else medium if medium_points in 2..4; else low (no factors or one Medium 1). medium_points sums Medium 1 (=1: elevated_troponin, elevated_bnp, hypertension, diabetes, ckd, previous_non_anthracycline_chemo, current_or_significant_smoker, obesity) and Medium 2 (=2: lvef_percent 50-54, age_years 65-79) only. Age and LVEF use the highest matching printed band. Lyon 2020 HFA-ICOS anthracycline table. cardiotoxicity_guide is that paper's expert-opinion guide: low <2%, medium 2-9%, high 10-19%, very high >=20%",
"cardiotoxicity_guide": "<2%"
}
]
}
}
}Cite this page
The pinned URL below renders this page from the snapshot of 2026-10-02 05:34 UTC and does not change; the live page does, every six hours. Data reuse is under CC BY 4.0 (terms).
Plain text
TOLL, "calc hfa icos anthracycline on api.magentlab.com", snapshot of 2026-10-02 05:34 UTC. https://tollindex.com/e/api-magentlab-com-api-calc-hfa-icos-anthracycline-0120c0/at/2026-10-02T05-34Z. Accessed [access date].
BibTeX
@misc{toll-e-api-magentlab-com-api-calc-hfa-icos-anthracycline-0120c0-2026-10-02T05-34Z,
author = {TOLL},
title = {calc hfa icos anthracycline on api.magentlab.com},
howpublished = {\url{https://tollindex.com/e/api-magentlab-com-api-calc-hfa-icos-anthracycline-0120c0/at/2026-10-02T05-34Z}},
year = {2026},
month = {10},
note = {Pinned view of the snapshot of 2026-10-02 05:34 UTC. Accessed [access date].}
}None yet. Anything submitted through the form below is published here with its outcome.